Pharma Mar SA (PHMMF)
94.60
0.00 (0.00%)
USD |
OTCM |
Sep 24, 16:00
Pharma Mar Cash and Short Term Investments (Quarterly) : 193.08M for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 193.08M |
| March 31, 2026 | 193.40M |
| December 31, 2025 | 196.40M |
| September 30, 2025 | 172.33M |
| June 30, 2025 | 150.35M |
| March 31, 2025 | 152.14M |
| December 31, 2024 | 160.01M |
| September 30, 2024 | 161.15M |
| June 30, 2024 | 144.84M |
| March 31, 2024 | 172.50M |
| December 31, 2023 | 179.57M |
| September 30, 2023 | 184.60M |
| June 30, 2023 | 201.72M |
| March 31, 2023 | 198.96M |
| December 31, 2022 | 194.69M |
| September 30, 2022 | |
| June 30, 2022 | 205.64M |
| March 31, 2022 | 246.55M |
| December 31, 2021 | 229.58M |
| September 30, 2021 | 256.26M |
| June 30, 2021 | 257.02M |
| March 31, 2021 | 246.88M |
| December 31, 2020 | 239.22M |
| September 30, 2020 | 231.30M |
| June 30, 2020 | 256.20M |
| Date | Value |
|---|---|
| March 31, 2020 | 190.49M |
| December 31, 2019 | 23.45M |
| September 30, 2019 | 25.52M |
| June 30, 2019 | 44.79M |
| March 31, 2019 | 15.47M |
| December 31, 2018 | 30.72M |
| September 30, 2018 | 30.39M |
| June 30, 2018 | 17.14M |
| March 31, 2018 | 19.54M |
| December 31, 2017 | 38.14M |
| September 30, 2017 | 16.16M |
| June 30, 2017 | 22.39M |
| March 31, 2017 | 12.76M |
| December 31, 2016 | 15.07M |
| September 30, 2016 | 11.91M |
| June 30, 2016 | 9.591M |
| March 31, 2016 | 7.464M |
| December 31, 2015 | 8.287M |
| September 30, 2015 | 44.13M |
| June 30, 2015 | 25.56M |
| March 31, 2015 | 33.00M |
| December 31, 2014 | 42.95M |
| September 30, 2014 | 46.00M |
| June 30, 2014 | 48.51M |
| March 31, 2014 | 45.86M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Oryzon Genomics SA | 16.79M |
| Grifols SA | 586.51M |
| ACADIA Pharmaceuticals, Inc. | 956.47M |
| Alkermes Plc | 656.58M |
| Alnylam Pharmaceuticals, Inc. | 3.308B |